Detection and analysis of the new kind of G743C and G743A point mutation of HBV P gene in hepatitis B virus infected patients resistant to lamivudine.
- Author:
Xiao-ping PAN
1
;
Jian-er WO
;
Zhi CHEN
;
Feng CHEN
;
Wei-feng LIANG
;
Ke-zhou LIU
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Amino Acid Motifs; genetics; Antiviral Agents; pharmacology; therapeutic use; Cloning, Molecular; DNA Primers; genetics; DNA, Viral; blood; genetics; DNA-Directed DNA Polymerase; genetics; Drug Resistance, Viral; genetics; Female; Gene Products, pol; genetics; Hepatitis B virus; genetics; Hepatitis B, Chronic; drug therapy; virology; Humans; Lamivudine; pharmacology; therapeutic use; Male; Middle Aged; Point Mutation
- From: Chinese Journal of Hepatology 2003;11(10):616-618
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo explore the point mutation in hepatitis B virus polymerase (HBV P) gene in HBV-infected patients resistant to lamivudine.
METHODSHBV P gene was amplified by PCR and the products was sequenced to analyze the YMDD mutation. Then the variants were detected by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) with the following restriction enzymes: Fok I, Ssp I, Alw441 and were separated by 8.0% polyacrylamide gel electrophoresis.
RESULTSComparing with the sequences of standard HBV genome, there were 16 patients with G743C mutation and 1 patient with G743A mutation, and the codon ATG turned to ATC and ATA, YMDD motif changed into YIDD. But this kind of YIDD mutation was not proved by PCR-RFLP assay in the 17 patients.
CONCLUSIONSThe G743C and G743A mutations in HBV P gene, resulting in YMDD motif changed into YIDD, are detected only by direct sequencing, not by PCR-RFLP. The new kind of G743C and G743A point mutations in HBV P gene is important for the detection of HBV P gene YMDD mutation.